Lin, Swan http://orcid.org/0000-0002-7705-9401
Shaik, Naveed
Chan, Geoffrey
Cortes, Jorge E.
Ruiz-Garcia, Ana
Clinical trials referenced in this document:
Documents that mention this clinical trial
An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure
https://doi.org/10.1007/s00280-020-04132-x
Funding for this research was provided by:
Pfizer
Article History
Received: 30 April 2020
Accepted: 22 August 2020
First Online: 3 September 2020
Compliance with ethical standards
:
: SL, NS, and GC are employees of Pfizer. AR-G was a former Pfizer employee. JEC received research funding to his institution and consulting honoraria from Pfizer, Novartis, Astellas, Daiichi Sankyo, Jazz Pharmaceuticals, Takeda, and Celgene.
: The study was conducted in accordance with the Declaration of Helsinki. All patients provided written informed consent before study procedures began, and the protocol was approved by institutional review boards at each study site.
: Informed consent was obtained from all individual participants included in the clinical studies that formed the basis of this pharmacokinetic/pharmacodynamic analysis.
: Not applicable.